Randomized comparative study of omeprazole and famotidine in reflux esophagitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 9, 2002, Pages 955-959

  Kawano, Sunao ^a   Murata, Hiroaki ^b   Tsuji, Shingo ^b   Kubo, Mitsuhiko ^c   Tatsuta, Masaharu ^d   Iishi, Hiroyasu ^d   Kanda, Tsutomu ^e   Sato, Tomonobu ^e   Yoshihara, Harumasa ^f   Masuda, Eiji ^f   Noguchi, Masahiko ^g   Kashio, Shinji ^g   Ikeda, Masahiro ^h   Kaneko, Akira ^h  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e OSAKA GENERAL MEDICAL CENTER   (Japan)

^f OSAKA ROSAI HOSPITAL   (Japan)

^g KANSAI ROSAI HOSPITAL   (Japan)

^h OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

Famotidine; Healing rate; Omeprazole; Randomized comparative study; Reflux esophagitis; Symptom relief rate

Indexed keywords

FAMOTIDINE; OMEPRAZOLE;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG EFFICACY; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REFLUX ESOPHAGITIS; SEX; SIDE EFFECT; SMOKING; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME; ULCER HEALING;

EID: 0036378334     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02785.x     Document Type: Article

References (19)

1. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in Japanese. Gut 1997; 41: 452-8.
2. Maekawa T, Kinoshita Y, Okada A et al. Relationship between severity and symptom of reflux oesophagitis in elderly patients in Japan. J. Gastroenterol. Hepatol. 1998; 13: 927-30.
3. Furukawa N, Iwakiri R, Koyama T et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J. Gastroenterol. 1999; 34: 441-4.
4. Koike T, Ohara S, Sekine H et al. Helicobacter pylori infection prevents erosive reflux esophagitis by decreasing gastric acid secretion. Gut 2001; 49: 330-4.
5. Haruma K, Hamada H, Kamada T et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000; 5: 24-9.
6. Labenz J, Blum AL, Bayerdörffer E et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
7. Asaka M, Kato M, Kudo M et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996; 1: 52-6.
8. Klinkenber-Knol EC, Nalis F, Dent J et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000; 118: 661-9.
9. Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fun-doplication. N. Engl. J. Med. 1996; 334: 1018-22.
10. Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
11. Vigneri S, Termini R, Leangro G et al. A comparison of five maintenance therapies for reflux esophagitis. N. Engl. J. Med. 1995; 333: 1106-10.
12. Ducrotte P, Guillemot F, Elouaer-Blanc L et al. Comparison of omeprazol and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over study. Am. J. Gastroenterol. 1994; 89: 717-21.
13. DeVault KR, Castell DO. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Arch. Intern. Med. 1995; 155: 2165-73.
14. Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux disease management--the Genval Workshop Report. Gut 1999;44 (Suppl. 2): S1-16.
15. Reynolds JC. Individualized acute treatment strategies for gastroesophageal reflux disease. Scand. J. Gastroenterol. 1995; 30 (Suppl. 213): 17-24.
16. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed and healing symptom relief in grade II to IV gastroesophageal reflux disease: Meta-analysis. Gastroenterology 1997; 112: 1798-810.
17. Soga T, Matsuura M, Kodama Y et al. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J. Gastroenterol. 1999; 3: 435-40.
18. Umeda N, Miki K, Hoshino E. Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study. J. Clin. Gastroenterol. 1995; 20 (Suppl. 1): S17-23.
19. Sekiguchi T, Nishioka T, Matsuzaki T et al. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis. Gastroenterol. Jpn. 1991; 26: 137-44.